Accelerated Approval Integrity Act of 2022
Sponsored By: Representative Pallone, Frank [D-NJ-6]
Unknown
Summary
Accelerated Approval Integrity Act of 2022 This bill establishes requirements relating to postapproval studies for drugs that receive accelerated approval for serious or life-threatening diseases or conditions, such as requiring product sponsors to agree in advance to conduct such studies and terminating product approval if certain benchmarks are not met.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Pallone, Frank [D-NJ-6]
NJ • D
Cosponsors
Rep. Maloney, Carolyn B. [D-NY-12]
NY • D
Sponsored 3/16/2022
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov